Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF
Author(s): Barry Borlaug Added: 3 months ago
HFSA 25 - Sex-specific outcomes of tirzepatide in obesity-related HFpEF showed that at baseline, women with HFpEF had more severe heart failure symptoms.Dr Barry Borlaug (Mayo Clinic, US) joins us to discuss a prespecified secondary analysis from the SUMMIT trial, examining sex-specific effects of tirzepatide in patients with heart failure with preserved ejection fraction and obesity.The SUMMIT… View more

Cardiovascular Renal Metabolic

Heart Failure
Sex Difference in Relative Survival Following PCI
Author(s): Jin-Ho Choi , Jung-Min Choi , Ki-Hong Choi , et al Added: 1 year ago

Demographic

Intervention
ESC 25: STRIDE: Outcomes by Sex
Author(s): Subodh Verma Added: 4 months ago
ESC Congress 2025 - New findings from STRIDE further demonstrate effectiveness of semaglutide in improving functional outcomes in PAD.Dr Subodh Verma joins us to discuss new findings from the STRIDE study, which investigated semaglutide 1.0mg in individuals with peripheral artery disease (PAD). 792 participants were enrolled in the trial, 24.6% of which were female, and 75.4% male.Findings showed… View more

Prevention & Chronic Conditions

Vascular Disease and Surgery
Women's Cardiovascular Health: Addressing Sex Differences, Cardio-Obstetrics & the Heart Team Approach
Author(s): Mirvat Alasnag , Julia Grapsa , Ahmed Krimly Added: 1 year ago
Join this insightful discussion on women's cardiovascular health!ICR3 Guest Editor, Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA), leads a conversation with Drs Julia Grapsa (Guy's and St Thomas' NHS Foundation Trust, UK) and Ahmed Krimly (King Faisal Cardiac Center, SA), authors of a special focus issue on this critical topic.Key themes explored:Disparities in heart failure care for… View more

CV Disease in Special Populations

Demographic
HFA 24 Late-breaking Discussion: Findings from PACT-HF
Author(s): Harriette Van Spall , Tauben Averbuch Added: 1 year ago
HFA 2024 — Dr Tauben Averbuch and Dr Harriette Van Spall (McMaster University, Hamilton, CA) discuss the findings from the PACT-HF trial. In this analysis of PACT-HF, investigators looked at long term sex-specific clinical outcomes and healthcare resource utilisation following hospitalisation for heart failure at 5 years.Findings shows that clinical outcomes and overall costs were similar between… View more

Demographic

Heart Failure
HFSA 2025 Late-Breaking Science Collection
Author(s): Nir Uriel Added: 3 months ago
Discover the latest heart failure data from impactful trials and studies presented at the Heart Failure Society of America's annual congress, HFSA 2025.For quick and practical summaries of the late-breaking trials, watch our 5-minute Expert Interviews conducted with the investigators. View more

Cardiovascular Renal Metabolic

Guidelines & Statements
Complex Cases: Aortic Stenosis in Women with Prof Karam
Author(s): Nicole Karam Added: 5 months ago
Discover the sex-specific challenges in aortic stenosis diagnosis and management with Prof Nicole Karam (European Hospital Georges Pompidou, Paris, FR).This presentation, part of a comprehensive two-part series on complex cases in interventional cardiology, explores the critical pathophysiological differences between men and women that impact diagnostic approaches and therapeutic decision-making… View more

Demographic

Intervention
Clinical Clues in Cardiovascular Disease
Author(s): Eva Gerdts , Faizel Osman , Yassir Javaid Added: 4 months ago
This six-part interview series, recorded around ESC 2025, brings together leading experts to share strategies for earlier and more accurate detection of cardiovascular disease. The discussions highlight how atypical or subtle symptoms of stroke and heart failure can delay diagnosis, and why vigilance in routine practice is critical.The series also examines sex-specific differences in cardiac… View more

CV Disease in Special Populations

Electrophysiology & Arrhythmia
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors
Author(s): Christina Magnussen Added: 9 months ago
ACC 2025 - Individual-level data collected across 126 worldwide cohorts show controlling modifiable cardiovascular risk factors can potentially benefit life-years for freedom from CVD and death from any cause.Prof Christina Magnussen (University Heart and Vascular Centre Hamburg, Hamberg, DE) joins us onsite at ACC to discuss modifiable cardiovascular risk factors collected by the Global… View more

Cardiovascular Renal Metabolic
Eva Gerdts
Research Area(s) / Expertise:

Gender

Hypertension

Obesity

Aortic Disease - General

 Job title: Chief of the Non-invasive Cardiac Imaging Unit
Prof Eva Gerdts is a Professor of Cardiology at the University of Bergen, Norway, andChief of the Non-invasive Cardiac Imaging Unit at theHaukeland University Hospital.She has published more than 240 scientific papers in peer-reviewed journals. Prof Gerdts is a licensed specialist in internal medicine and cardiology in Norway, and graduated from the University of Bergen School of Medicine in 1981… View more